4//SEC Filing
Butler John P. 4
Accession 0001562180-25-001998
CIK 0001517022other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:05 PM ET
Size
8.0 KB
Accession
0001562180-25-001998
Insider Transaction Report
Form 4
Butler John P.
DirectorCEO and President
Transactions
- Sale
Common Stock
2025-03-03$1.83/sh−46,409$84,928→ 2,557,921 total
Holdings
- 59,928(indirect: Held by John Butler 2019 GRAT)
Common Stock
- 100,000(indirect: Held By John Butler GRAT November 2019)
Common Stock
- 100,000(indirect: Held By Dorothy Butler GRAT November 2019)
Common Stock
- 59,928(indirect: Held by Dorothy Butler 2019 GRAT)
Common Stock
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001591467
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:05 PM ET
- Size
- 8.0 KB